{
    "code": "02022712",
    "url": "http:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02022712",
    "time": "2016-06-24 04:54:53",
    "許可證字號": "衛署藥輸字第022712號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "108\/12\/21",
    "發證日期": "88\/12\/21",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202271201",
    "中文品名": "艾黴素注射液",
    "英文品名": "ADRIAMYCIN INJ. 2MG\/ML",
    "適應症": "急慢性白血球過多症、硬瘤、淋巴瘤、軟纖維性肉瘤、交感神經母細胞瘤、乳癌、肝癌。",
    "劑型": "270注射劑",
    "包裝": "5ML,10ML,25ML塑膠小瓶 100支以下盒裝",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "DOXORUBICIN HYDROCHLORIDE",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "新北市淡水區中正東路二段１７７號",
    "主製造廠": {
        "製造廠名稱": "F020034000  PFIZER (PERTH) PTY LIMITED",
        "製造廠廠址": "15 BRODIE HALL DRIVE TECHNOLOGY PARK, BENTLEY WESTERN AUSTRALIA 6102",
        "製造廠公司地址": "",
        "製造廠國別": "AUSTRALIA",
        "製程": ""
    },
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1003000620",
            "成分名稱": "DOXORUBICIN HYDROCHLORIDE",
            "含量描述": "",
            "含量": "2.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020227120001-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=007&Type=9"
        },
        {
            "title": "Adriamycin 藥輸022712-103-02-21.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=006&Type=9"
        },
        {
            "title": "020227120004___20120815.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=005&Type=9"
        },
        {
            "title": "020227120003___20120815.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=004&Type=9"
        },
        {
            "title": "020227120002___20120815.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=003&Type=9"
        },
        {
            "title": "020227120001___20120815.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=002&Type=9"
        },
        {
            "title": "020227120001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=001&Type=9"
        },
        {
            "title": "Adriamycin 50mg-LAB-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=006&Type=8"
        },
        {
            "title": "Adriamycin 50mg-CTN-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=005&Type=8"
        },
        {
            "title": "Adriamycin 20mg-LAB-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=004&Type=8"
        },
        {
            "title": "Adriamycin 20mg-CTN-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=003&Type=8"
        },
        {
            "title": "Adriamycin 10mg-LAB-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=002&Type=8"
        },
        {
            "title": "Adriamycin 10mg-CTN-050421-105-04-27.pdf",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02022712&Seq=001&Type=8"
        }
    ]
}